According to Collegium Pharmaceutical 's latest financial reports the company's total debt is โฌ0.71 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | โฌ0.82 B | 35.38% |
2023-12-31 | โฌ0.60 B | -7.74% |
2022-12-31 | โฌ0.66 B | 189.36% |
2021-12-31 | โฌ0.22 B | 5.42% |
2020-12-31 | โฌ0.21 B | 1024.36% |
2019-12-31 | โฌ19.27 M | 91.76% |
2018-12-31 | โฌ10.05 M | 715.52% |
2017-12-31 | โฌ1.23 M | -68.73% |
2016-12-31 | โฌ3.94 M | -36.74% |
2015-12-31 | โฌ6.23 M | -41.74% |
2014-12-31 | โฌ10.69 M | 1417.93% |
2013-12-31 | โฌ0.7 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Agile Therapeutics
AGRX | โฌ0.24 M | -99.97% | ๐บ๐ธ USA |
![]() Horizon Therapeutics
HZNP | โฌ2.17 B | 202.94% | ๐ฎ๐ช Ireland |
![]() United Therapeutics UTHR | โฌ0.16 B | -76.31% | ๐บ๐ธ USA |
![]() KemPharm KMPH | โฌ19.62 M | -97.26% | ๐บ๐ธ USA |